• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断前体重指数、身体活动与卵巢癌死亡率。

Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, United States of America.

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States of America; Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.

出版信息

Gynecol Oncol. 2019 Oct;155(1):105-111. doi: 10.1016/j.ygyno.2019.07.025. Epub 2019 Aug 2.

DOI:10.1016/j.ygyno.2019.07.025
PMID:31383570
Abstract

BACKGROUND

Ovarian cancer is the deadliest gynecologic malignancy, yet the effects on survival of modifiable pre-diagnosis lifestyle factors, such as obesity and physical activity, remain largely unexplored. Our objective was to evaluate the effect of pre-diagnosis BMI and physical activity on ovarian cancer mortality using prospectively collected data.

METHODS

Data on women who developed ovarian cancer after enrollment into the NIH-AARP Diet and Health Study were analyzed. Cancer incidence was ascertained through linkage state cancer registries and consisted of 741 cases of epithelial ovarian cancer.

RESULTS

Higher pre-diagnosis BMI was associated with increased overall and ovarian cancer-specific mortality. Comparing women with BMI 25-29.9, 30-34.9 and ≥ 35 to normal weight women, the HRs of overall mortality were 1.18 (95%CI 0.96-1.45), 1.05 (0.82-1.36) and 1.59 (1.14-2.18, p-trend = 0.02). The findings were similar for ovarian cancer-specific mortality comparing women with BMI ≥ 35 to normal weight women (BMI <25) with a HR of 1.47 (95%CI 1.03-2.09, p-trend 0.08). Pre-diagnosis physical activity was not associated with mortality, with HRs for overall mortality of 1.06 (95%CI 0.79-1.43), 0.94 (0.72-1.23), 0.98 (0.76-1.25), and 0.98 (0.75-1.28, p-trend = 0.91), comparing women who engaged in vigorous physical activity 1-3 times/month, 1-2 times/week, 3-4 times/week and 5 times/week, respectively, with those who never/rarely engaged in such activity.

CONCLUSIONS

Women who were obese before developing ovarian cancer had increased mortality than those who were normal weight, but physical activity before diagnosis was not associated with mortality in this study population. These results suggest that maintaining a healthy weight is a powerful preventative tool.

摘要

背景

卵巢癌是最致命的妇科恶性肿瘤,但可改变的诊断前生活方式因素(如肥胖和身体活动)对生存的影响在很大程度上仍未得到探索。我们的目的是使用前瞻性收集的数据评估诊断前 BMI 和身体活动对卵巢癌死亡率的影响。

方法

分析了参加美国国立卫生研究院-美国退休人员协会饮食与健康研究后被诊断患有卵巢癌的女性的数据。癌症发病率通过州癌症登记处的联系确定,包括 741 例上皮性卵巢癌病例。

结果

较高的诊断前 BMI 与总死亡率和卵巢癌特异性死亡率增加有关。与正常体重女性相比,BMI 为 25-29.9、30-34.9 和≥35 的女性的总死亡率 HR 分别为 1.18(95%CI 0.96-1.45)、1.05(0.82-1.36)和 1.59(1.14-2.18,p 趋势=0.02)。与 BMI<25 的正常体重女性相比,BMI≥35 的女性卵巢癌特异性死亡率也类似(BMI<25),HR 为 1.47(95%CI 1.03-2.09,p 趋势 0.08)。诊断前身体活动与死亡率无关,总死亡率的 HR 分别为 1.06(95%CI 0.79-1.43)、0.94(0.72-1.23)、0.98(0.76-1.25)和 0.98(0.75-1.28,p 趋势=0.91),分别比较每月 1-3 次、1-2 次/周、3-4 次/周和每周 5 次剧烈运动的女性与从不/很少进行此类活动的女性。

结论

在诊断为卵巢癌之前肥胖的女性比体重正常的女性死亡率更高,但在本研究人群中,诊断前的身体活动与死亡率无关。这些结果表明,保持健康的体重是一种强大的预防工具。

相似文献

1
Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.诊断前体重指数、身体活动与卵巢癌死亡率。
Gynecol Oncol. 2019 Oct;155(1):105-111. doi: 10.1016/j.ygyno.2019.07.025. Epub 2019 Aug 2.
2
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.根据体质量指数评估化疗剂量对卵巢癌生存的影响。
JAMA Oncol. 2015 Sep;1(6):737-45. doi: 10.1001/jamaoncol.2015.1796.
3
Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative.体重指数、身体活动与确诊卵巢癌女性的死亡率:来自妇女健康倡议的结果。
Gynecol Oncol. 2014 Apr;133(1):4-10. doi: 10.1016/j.ygyno.2014.01.033.
4
Height, weight, BMI and ovarian cancer survival.身高、体重、BMI 与卵巢癌生存
Gynecol Oncol. 2012 Oct;127(1):83-7. doi: 10.1016/j.ygyno.2012.05.038. Epub 2012 Jun 16.
5
A healthy lifestyle and survival among women with ovarian cancer.健康的生活方式与卵巢癌患者的生存
Int J Cancer. 2020 Dec 15;147(12):3361-3369. doi: 10.1002/ijc.33155. Epub 2020 Jul 6.
6
Body mass index, physical activity, and television time in relation to mortality risk among endometrial cancer survivors in the NIH-AARP Diet and Health Study cohort.在国立卫生研究院-美国退休人员协会饮食与健康研究队列中,子宫内膜癌幸存者的体重指数、身体活动及看电视时间与死亡风险的关系。
Cancer Causes Control. 2016 Nov;27(11):1403-1409. doi: 10.1007/s10552-016-0813-7. Epub 2016 Oct 11.
7
The effect of body mass index and weight change on epithelial ovarian cancer survival in younger women: a long-term follow-up study.体质指数和体重变化对年轻女性上皮性卵巢癌生存的影响:一项长期随访研究。
J Womens Health (Larchmt). 2012 Aug;21(8):865-71. doi: 10.1089/jwh.2012.3487. Epub 2012 Jun 4.
8
Physical activity in different periods of life, sedentary behavior, and the risk of ovarian cancer in the NIH-AARP diet and health study.不同生命阶段的身体活动、久坐行为与 NIH-AARP 饮食与健康研究中的卵巢癌风险。
Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2000-8. doi: 10.1158/1055-9965.EPI-13-0154. Epub 2013 Aug 21.
9
Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.子宫内膜癌患者的预诊断体重指数、身体活动与死亡率。
J Natl Cancer Inst. 2013 Mar 6;105(5):342-9. doi: 10.1093/jnci/djs530. Epub 2013 Jan 7.
10
Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.绝经后女性前瞻性队列研究中体重指数、身高与卵巢癌死亡风险
Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):822-8.

引用本文的文献

1
Physical Activity and Cancer Incidence and Mortality: Current Evidence and Biological Mechanisms.体力活动与癌症发病率和死亡率:当前证据及生物学机制
Cancers (Basel). 2025 Apr 23;17(9):1410. doi: 10.3390/cancers17091410.
2
Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.化疗前体重指数对卵巢癌女性患者预后的潜在影响
Nutrients. 2025 Jan 31;17(3):556. doi: 10.3390/nu17030556.
3
Investigation of the trends and associated factors of ovarian cancer in Indonesia: A systematic analysis of the Global Burden of Disease study 1990-2021.
印度尼西亚卵巢癌的趋势及相关因素调查:1990 - 2021年全球疾病负担研究的系统分析
PLoS One. 2025 Jan 17;20(1):e0313418. doi: 10.1371/journal.pone.0313418. eCollection 2025.
4
Epidemiological trends and risk factors of gynecological cancers: an update.妇科癌症的流行病学趋势和风险因素:最新研究进展。
Med Oncol. 2023 Feb 9;40(3):93. doi: 10.1007/s12032-023-01957-3.
5
Obesity and endocrine-related cancer: The important role of IGF-1.肥胖与内分泌相关癌症:IGF-1 的重要作用。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1093257. doi: 10.3389/fendo.2023.1093257. eCollection 2023.
6
Preoperative carcinoembryonic antigen to body mass index ratio contributes to prognosis prediction in colorectal cancer.术前癌胚抗原与体重指数之比有助于预测结直肠癌的预后。
Oncol Lett. 2022 Sep 29;24(5):416. doi: 10.3892/ol.2022.13536. eCollection 2022 Nov.
7
Metabolic risk factors of ovarian cancer: a review.卵巢癌的代谢风险因素:综述。
JBRA Assist Reprod. 2022 Apr 17;26(2):335-347. doi: 10.5935/1518-0557.20210067.
8
Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.术前低血细胞比容是卵巢癌不良预后的生物标志物。
Arch Gynecol Obstet. 2021 Mar;303(3):767-775. doi: 10.1007/s00404-020-05822-w. Epub 2020 Oct 3.
9
Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.在临床试验 1 期接受治疗的卵巢癌患者的生存和临床结局。
Cancer. 2020 Oct 1;126(19):4289-4293. doi: 10.1002/cncr.33073. Epub 2020 Jul 22.